Skip to main content
. 2022 Jul 28;12:953780. doi: 10.3389/fcimb.2022.953780

Table 1.

Antimicrobial MICs (mg/L) and susceptible rates of 197 E. anophelis isolates determined using the agar dilution.

Antimicrobial agent Susceptibility testing assay
Agar dilution (mg/L) MIC range S no. (%) I no. (%) R no. (%)
Piperacillin 0.5–256 8–>256 49 (24.87) 50 (25.38) 98 (49.75)
Piperacillin-tazobactam 0.5–256+4 4/4–>256/4 67 (34.01) 73 (37.06) 57 (28.93)
Ceftazidime 0.25–64 4–>64 1 (0.51) 0 (0) 196 (99.49)
Cefepime 0.06–64 2–>64 2 (1.02) 7 (3.55) 188 (95.43)
Imipenem 0.03–32 0.25–>32 1 (0.51) 0 (0) 196 (99.49)
Meropenem 0.008–32 0.06–>32 2 (1.02) 0 (0) 195 (98.98)
Aztreonam 0.03–64 32–>64 0 (0) 0 (0) 197 (100)
Gentamicin 0.125–32 4–>32 7 (3.55) 16 (8.13) 174 (88.32)
Amikacin 0.25–128 4–>128 12 (6.09) 31 (15.74) 154 (78.17)
Minocycline 0.125–32 0.25–2 197 (100) 0 (0) 0 (0)
Doxycycline 0.25–32 0.5–16 189 (95.94) 7 (3.56) 1 (0.5)
Tetracycline 0.25–32 1–>32 5 (2.54) 14 (7.1) 178 (90.36)
Tigecycline 0.015–32 0.5–16 70 (35.53) 97 (49.24) 30 (15.23)
Ciprofloxacin 0.004–8 0.125–>8 95 (48.22) 49 (24.88) 53 (26.9)
Levofloxacin 0.008–16 0.125–>16 150 (76.14) 8 (4.06) 39 (19.8)
Trimethoprim-sulfamethoxazole 0.25–8+4.75–152 4/38–>8/152 2 (1.02) 0 (0) 195 (98.98)
Rifampin 0.25–32 0.25–32 185 (93.91) 3 (1.52) 9 (4.57)
Vancomycin 0.25–64 4–>64 1 (0.51) 146 (74.11) 50 (25.38)
Chloramphenicol 1–64 8–>64 11 (5.58) 73 (37.06) 113 (57.36)

R, resistant; S, susceptible; I, intermediate resistant.